NCT02214862View on ClinicalTrials.gov

2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Progressive Supranuclear PalsyMulti-System AtrophyParkinsonism
Interventions
DRUG

[F18]-FDDNP

radiopharmaceutical tracer

Trial Locations (1)

08036

Hospital Clinic, Barcelona

All Listed Sponsors
lead

Fundacion Clinic per a la Recerca Biomédica

OTHER

NCT02214862 - 2-(1-{6-[(2-[F-18]Fluoroethyl) (Methyl)Amino]-2-naphthyl} Ethylidene) Malononitrile-PET for in Vivo Diagnose of Tauopathy in Unclassified Parkinsonism | Biotech Hunter | Biotech Hunter